Whole pancreas has been used successfully for transplantation for more than 30 years, and islets have been used reproducibly with success for 10 years; both procedures require drugs for immunosuppression. Success is judged by discontinuation of exogenous insulin-based treatment and maintenance of normal or nearly normal hemoglobin A1c. Successful pancreas transplantation has beneficial effects on retinopathy, nephropathy, neuropathy, macrovascular disease, and quality of life. Such findings are suggested for islet transplantation, but insufficient information is available to draw firm conclusions. Because of the paucity of annual pancreas donations, research for human beta cell surrogates is essential to provide a transplantation approach to therapy for a greater number of recipients.
|Original language||English (US)|
|Number of pages||13|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Sep 2010|
Bibliographical noteFunding Information:
This work was supported by Grant No. NIDDK RO1 39994 from the National Institutes of Health .
Copyright 2011 Elsevier B.V., All rights reserved.
- Beta cells
- Islet transplantation
- Pancreas transplantation
- Type 1 diabetes